DARE - Dare Bioscience - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DARE is currently covered by 4 analysts with an average price target of $16.46. This is a potential upside of $13.43 (443.23%) from yesterday's end of day stock price of $3.03.

Dare Bioscience's activity chart (see below) currently has 4 price targets and 17 ratings on display. The stock rating distribution of DARE is 90.91% BUY and 9.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 132.5 days.

Highest price target for DARE is $13, Lowest price target is $12, average price target is $7.5.

Most recent stock forecast was given by DOUGLAS TSAO from HCWAINWRIGHT on 01-Apr-2025. First documented stock forecast 17-Aug-2018.

Currently out of the existing stock ratings of DARE, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$9.03 (304.04%)

$12

2 months 1 days ago
(01-Apr-2025)

0/5 (0%)

$9.1 (313.79%)

Buy

$13

$10.03 (337.71%)

9 months 17 days ago
(16-Aug-2024)

0/1 (0%)

$9.43 (264.15%)

Hold

$4

9 months 19 days ago
(14-Aug-2024)

1/1 (100%)

$-15.44 (-79.42%)

660

Buy

$3

$0.09 (3.09%)

1 years 19 days ago
(15-May-2024)

2/2 (100%)

$-1.32 (-30.56%)

135

Buy

$2

$-0.97 (-32.66%)

1 years 9 months 3 days ago
(30-Aug-2023)

0/1 (0%)

$-6.52 (-76.53%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DARE (Dare Bioscience) average time for price targets to be met?

On average it took 132.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on DARE (Dare Bioscience) with a proven track record?

KEMP DOLLIVER

Which analyst has the current lower performing score on DARE (Dare Bioscience) with a proven track record?

CATHERINE NOVACK

Which analyst has the most public recommendations on DARE (Dare Bioscience)?

Kemp Dolliver works at BROOKLINE and has 5 price targets and 3 ratings on DARE

Which analyst is the currently most bullish on DARE (Dare Bioscience)?

Catherine Novack with highest potential upside - $10.03

Which analyst is the currently most reserved on DARE (Dare Bioscience)?

Jason Kolbert with lowest potential downside - -$0.97

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?